Evaluating the Addition of OK-1 Weekly Paclitaxel in Patients With Endometrial Cancer

NCT07737795 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Endometrial Cancer

Interventions

DRUG: OK-1 & Paclitaxel

Sponsor

University of Oklahoma

Collaborators

[object Object]